Real-time engagement app to improve glycemic control in adolescents and young adults with type 2 diabetes
Official title: Real-time Engagement for Learning to Effectively Control Type 2 Diabetes
Run by University of Pittsburgh · NCT06375460 · Data updated 2026-11-12
A smartphone app that combines glucose, activity, and diet data is tested to see if it helps teens and young adults with type 2 diabetes manage their blood sugar better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years to 26 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | September 20, 2026 |
| Main results expected | July 2029 |
| Study ends | August 2029 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT06375460 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescents and young adults with type 2 diabetes who speak English and do not have autoantibody-positive diabetes or monogenic diabetes suspicion.
✕Probably not a fit
Individuals with current pregnancy, cognitive or severe psychiatric conditions, eating disorders, or hydroxyurea use may not experience benefit or may be excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
REFLECT2D tests whether real-time, linked glucose and health-behavior data via a mobile app can improve glycemic control in adolescents and young adults with type 2 diabetes. After an education session and run-in, participants undergo a 90-day micro-randomized trial assigning them to a daily prompt focused on physical activity, a prompt focused on diet, or no prompt, followed by a 90-day observation period. Participants wear a continuous glucose monitor and a fitness tracker, use the app for 6 months, and provide occasional dietary logs and in-person visits with fasting blood draws. The study evaluates short- and longer-term changes in glycemic control and the persistence of these changes after prompts end.
Why it matters
Potential benefit: If successful, the app could help users better interpret glycemic data and sustain healthier behaviors to improve blood sugar control.
How similar studies have gone: Prior studies in diabetes behavior interventions suggest that real-time data feedback can support behavior change, but this specific MRT-based digital approach in youth-onset type 2 diabetes is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * type 2 diabetes: negative diabetes autoantibodies, no suspicion for monogenic diabetes * English-speaking (app in English) Exclusion Criteria: * Current pregnancy * Hydroxyurea use (CGM sensor inaccuracies) * Cognitive impairment or severe psychiatric condition that could interfere with participation in behavioral intervention for diabetes self-management * Current or previously diagnosed eating disorder
Where it's running
-
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Mary Ellen Vajravelu, MD — University of Pittsburgh
- Study coordinator: Mary Ellen Vajravelu, MD
- Email: vajravelume@upmc.edu
- Phone: 412-692-6533
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Real-time app and wearable sensors to help young people control type 2 diabetes
This project will try a smartphone app together with a continuous glucose monitor and a Fitbit for English-speaking 16–24-year-olds diagnosed with type 2 diabetes before age 18 to learn which messages and features help with activity and glucose monitoring.
-
Exploring how lifestyle factors relate to cardiovascular health
This study looks at how things like exercise, stress, and diet affect heart health in both adults and children.
-
Eating window timing to improve blood sugar in adults with obesity and type 2 diabetes or at risk
This study tests whether eating only during one of three nine-hour daily windows can improve blood sugar control in adults with obesity who have or are at risk for type 2 diabetes.
-
Proliverenol for liver fat and insulin resistance in type 2 diabetes
This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
-
Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes
This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.